Antidepressant drug product sales plummet as patents expire and individuals flee to safer alternatives The market for antidepressant drugs is quickly drying up as patents about long-period blockbusters like Lexapro, owned by Forest Laboratories, and Seroquel, owned by AstraZeneca, continue to expire. And because they are unable to develop fresh multi-billion-dollar blockbuster medicines to take their areas, many drug producers are ditching the antidepressant business altogether, especially as studies continue steadily to emerge showing that antidepressants are useless and cause more harm than good generally. A recently available Reuters report appears to bemoan the actual fact that development of a fresh antidepressant medication ceased after it had been discovered that the medication was ineffective.The Breastfeeding, Antiretrovirals and Nourishment study may be the only large-level, randomized trial comparing baby prophylaxis or maternal treatment to a sophisticated standard-of-care arm in the prevention of HIV transmission through breasts milk. The study was carried out in Lilongwe, Malawi at a single site. Investigators randomly assigned at total of 2,367 mother-infant pairs to one of three treatment hands. For both the interventions, the probability of HIV-infection was less than in the enhanced control arm significantly.